Advertisement

Calcified Tissue International

, Volume 55, Issue 3, pp 240–240 | Cite as

Oral pamidronate in refractory Paget's disease

  • Emilio J. A. Roldán
  • S J Wimalawansa
  • R D Gunasekera
Letters to the Editor
  • 14 Downloads

Keywords

Pamidronate Oral Pamidronate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Wimalawansa SJ, Gunasekera RD (1993) Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. Calcif Tissue Int 53: 237–241Google Scholar
  2. 2.
    Mautalen CA (1983) Treatment of Paget's bone disease with the bisphosphonate APD. Henry Ford Hosp Med J 31: 244–248Google Scholar
  3. 3.
    Fromm GA, Plantalech L, Casco C, Gonzalez D, Mautalen (1984) Treatment of Paget's bone disease with a bisphosphonate. Medicina (Buenos Aires) 44: 245–251Google Scholar
  4. 4.
    Drake S, Massie JD, Postlethwaite AE, Palmieri GMO (1989) Pamidronate sodium and calcitonin-resistant Paget's disease: immediate response in a patient. Arch Intern Med 149: 401–403Google Scholar
  5. 5.
    Miravet L, Kuntz D (1989) L'amino-hydroxy-propylidene bisphosphonate dans le traitement des maladies de Paget resistantes a la calcitonine et/ou l'etidronate. Rev Rhumat 56: 287–292Google Scholar

References

  1. 6.
    Wimalawansa SJ, Gunasekera RD (1993) Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. Calcif Tissue Int 53: 237–241Google Scholar
  2. 7.
    Fleisch HA (1991) Bisphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42: 919–944Google Scholar
  3. 8.
    Wimalawansa SJ (1993) Hypercalcaemia of malignancy: etiology, pathogeneses and management. Rev Endocr Rel Cancer 45: 5–24Google Scholar
  4. 9.
    Harinck HIJ, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OLM (1987) Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). Br Med J 295: 1301–1305Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1994

Authors and Affiliations

  • Emilio J. A. Roldán
    • 1
  • S J Wimalawansa
  • R D Gunasekera
  1. 1.Department of Clinical PharmacologyGador S ABuenos AiresArgentina

Personalised recommendations